Arrowhead Research Corporation

ARWR XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

10B

Short interest (May 15)

9.2%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.28%

↑ 7.9%

Available Shares

↓ 26.6%

Price Chart

Company Overview

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0000879407

Asset Type: CS

Market Data

Market Cap: $9,975,494,227

Employees: 711

Status: Active

Short Interest

Current Borrow Fee 0.28%

Range: 0.27% - 0.28%

Available Shares 1M

Range: 1.1M - 1.4M

Recent Changes

Fee Change: ↑ 1.0%

Available Change: ↓ 10.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime